Home > Financial Ratios > ANUH PHARMA

ANUH PHARMA
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for ANUH PHARMA
Please provide your vote to see the results

ANUH PHARMA Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 51.689.98-5.38102.79-20.82

What is the latest Core EBITDA Growth ratio of ANUH PHARMA ?

The latest Core EBITDA Growth ratio of ANUH PHARMA is 51.68 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar202451.68
Mar20239.98
Mar2022-5.38
Mar2021102.79
Mar2020-20.82

How is Core EBITDA Growth of ANUH PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2024 51.68
417.84
Mar2023 9.98
Positive
Mar2022 -5.38
Negative
Mar2021 102.79
Positive
Mar2020 -20.82 -

Other Financial Ratios of ANUH PHARMA


Compare Core EBITDA Growth ratio of peers of ANUH PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ANUH PHARMA ₹825.1 Cr 7.4% 1.2% -30.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹400,293.0 Cr -1.7% 5.5% 5.4% Stock Analytics
DIVIS LABORATORIES ₹139,692.0 Cr -5.2% -4.6% 49% Stock Analytics
CIPLA ₹111,807.0 Cr -4.2% -2.4% -3.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,404.0 Cr 1.6% 8.4% 26.9% Stock Analytics
DR REDDYS LABORATORIES ₹90,843.0 Cr -5.5% -3.4% -9.4% Stock Analytics


ANUH PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ANUH PHARMA

7.4%

1.2%

-30.3%

SENSEX

-5.5%

0.2%

-1%


You may also like the below Video Courses